Stay updated on Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page.

Latest updates to the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page
- Check5 days agoChange DetectedAdded related topics Rheumatoid arthritis and MedlinePlus Genetics to the page's related resources section; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check26 days agoChange DetectedUpdated citation to reflect formal October 2025 issue publication; removed “Online ahead of print” status and adjusted publication date and minor author/name formatting.SummaryDifference0.1%

- Check34 days agoChange DetectedOverall, the page updates to announce a system status notice and a new software version (v3.2.0), removing the previous v3.1.0 reference.SummaryDifference0.8%

- Check41 days agoChange DetectedVersion bump to v3.1.0 with removal of a Rheumatoid arthritis topic from MedlinePlus Genetics topics.SummaryDifference0.1%

- Check55 days agoChange DetectedRegional naming updated and address reformatted to use 'Respublika'; revision upgraded from v3.0.1 to v3.0.2. Minor UI element 'Back to Top' removed.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page has been updated to include a new research article on the safety profile of Upadacitinib, and the version has been revised from v3.0.0 to v3.0.1.SummaryDifference0.6%

Stay in the know with updates to Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page.